Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Tampa, Florida 33607


Surgical resection of the affected liver offers the best chance for disease-free survival in patients with Hepatoma (HCC). Unfortunately, most hepatoma patients present with disease which is multi-focal and thus not resectable. Fewer than 15% of HCC patients are resectable. The objective of treatment with TheraSphere is to selectively administer a dose of radioactive material directly to neoplastic tissue in the liver. Systemic therapy is largely ineffective.

Study summary:

Protocol Objectives include: - Determine the proportion of patients with HCC in whom the treatment plan can be completed - Evaluate the response to therapy - Evaluate toxicities and adverse experiences associated with TheraSphere treatment - Evaluate survival time


Inclusion Criteria: - Over 18 years of age of any sex, race - Histological proof of HCC - Able to give Informed Consent - ECOG performance equal or less than 2 - Life expectancy equal to or greater than 3 months - Non- pregnant with acceptable contraception in premenopausal women - Greater than 4 weeks since prior radiation therapy or surgery - 1 month post chemotherapy - Serum Bilirubin < 2.0 - Acceptable white blood count Exclusion Criteria: - Co-morbid disease that would place patient at undue risk. - Pre-existing diarrhea/illness - Pregnant - Fail preliminary MAA testing



Primary Contact:

Principal Investigator
Alison R. Calkins, MD
St. Joseph's Hospital, Tampa, FL

Mary Pritchard, RN, OCN
Phone: 813-870-4257
Email: Mary.Pritchard@baycare.org

Backup Contact:

Email: Ronda.buffington@baycare.org
Ronda Buffington, RN, OCN
Phone: 813-870-4123

Location Contact:

Tampa, Florida 33607
United States

Ronda Buffington, RN,OCN
Phone: 813-870-4123
Email: Ronda.Buffington@baycare.org

Site Status: Recruiting

Data Source: ClinicalTrials.gov

Date Processed: November 18, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.